Cargando…
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy
BACKGROUND: Duchenne muscular dystrophy (DMD) is a lethal muscle disease detected in approximately 1:5000 male births. DMD is caused by mutations in the DMD gene, encoding a critical protein that links the cytoskeleton and the extracellular matrix in skeletal and cardiac muscles. The primary consequ...
Autores principales: | Amor, Fatima, Vu Hong, Ai, Corre, Guillaume, Sanson, Mathilde, Suel, Laurence, Blaie, Stephanie, Servais, Laurent, Voit, Thomas, Richard, Isabelle, Israeli, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200436/ https://www.ncbi.nlm.nih.gov/pubmed/34037326 http://dx.doi.org/10.1002/jcsm.12708 |
Ejemplares similares
-
miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy
por: Sanson, M., et al.
Publicado: (2020) -
A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy
por: Vu Hong, Ai, et al.
Publicado: (2021) -
Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy
por: Markati, Theodora, et al.
Publicado: (2021) -
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy
por: Bourg, Nathalie, et al.
Publicado: (2022) -
Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy
por: Vu Hong, Ai, et al.
Publicado: (2022)